LUYE PHARMA GROUP DL-,02 revenue for the last year amounted to 783.93 M EUR, the most of which — 272.04 M EUR — came from its highest performing source at the moment, Oncology Drugs, the year earlier bringing 320.72 M EUR. The greatest contribution to the revenue figure was made by China — last year it brought LUYE PHARMA GROUP DL-,02 644.67 M EUR, and the year before that — 699.78 M EUR.